ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0096

Delayed Referral of Female Rheumatoid Arthritis Patients: Where Are We Now? A Study Spanning Three Decades

Bastiaan van Dijk1 and Annette van der Helm-van Mil2, 1Leiden University Medical Centre (LUMC), Leiden, Netherlands, 2Leiden University Medical Center, Erasmus Medical Center, Leiden, Netherlands

Meeting: ACR Convergence 2022

Keywords: Cohort Study, Disparities, gender, practice guidelines, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Healthcare Disparities in Rheumatology Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Delayed referral of female RA-patients was reported twenty years ago: the time between the first appointment with the general practitioner (GP) and referral to the rheumatologist (‘referral delay’) was significantly longer in female than male RA-patients. In contrast, the time between symptom-onset and the first appointment with the GP (‘patient delay’) was similar in both sexes. Although rapid referral has been increasingly advocated and incorporated in guidelines during the past two decades, recent sex-specific data are lacking. Therefore, we assessed excess referral delay in female RA-patients over the past three decades in a unique regionwide inception cohort with 27 years of data.

Methods: 962 consecutive early RA-patients (630 women and 332 men) presenting at the Leiden Early Arthritis Clinic during three time-periods were studied: (1) 1993-2000;the reference period with known referral delay in females, (2) 2001-2010; with increased education of GPs on the importance of early referral, and (3) 2011-2020; with the addition of an easy-access screening clinic enabling very swift referral for patients in whom the GP doubts on the presence of arthritis. All education and instructions for GPs were not sex-specific. For each time-period we assessed referral, patient and total delay from symptom-onset to the first visit with the rheumatologist.

Results: Referral and patient delay are depicted in Figure 1A-C. Between 1993-2000, median referral delay was 4.4 weeks longer in female than male RA-patients (median (IQR) of 14.3 (6.1-26.0) vs. 9.9 (4.6-17.4) weeks; p=0.027). Thereafter, excess referral delay in female RA-patients decreased to a statistically insignificant difference of 1.7 weeks in 2001-2010. Finally, in 2011-2020, referral delay was similar in women and men (4.7 (1.9-12.9) and 5.4 (2.0-9.7); p=0.99). Patient-delay was stable and similar in both sexes. The percentage of RA-patients with total delay ≤12 weeks showed a similar time-pattern as referral delay (Figure 1D).

Conclusion: In the era of implementation of guidelines on early referral, excess referral delay in female RA-patients has improved.

Supporting image 1


Disclosures: B. van Dijk, None; A. van der Helm-van Mil, None.

To cite this abstract in AMA style:

van Dijk B, van der Helm-van Mil A. Delayed Referral of Female Rheumatoid Arthritis Patients: Where Are We Now? A Study Spanning Three Decades [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/delayed-referral-of-female-rheumatoid-arthritis-patients-where-are-we-now-a-study-spanning-three-decades/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/delayed-referral-of-female-rheumatoid-arthritis-patients-where-are-we-now-a-study-spanning-three-decades/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology